Home Conference Coverage

Conference Coverage

CD166 Expression Level and Anti-Cancer Activity Confirm Potential for Combination of...

Clinical and preclinical data for CX-2009, a Probody-drug Conjugate or PDC designed to target the cell surface protein CD166 and deliver the...

Anti-CD99 Targeted Nanosphere Shows Potential in Ewing’s Sarcoma

Despite key-advances in the development of novel anti-cancer therapeutics, off-target, adverse, effects plague drug developers. One reason is that standard chemotherapeutic...

Misdiagnosis of Colorectal Cancer May Be Common in People Younger than...

Results of a survey funded by the Colorectal Cancer Alliance and presented during a preview meeting of the Annual Meeting of the America Association...

Despite Receiving Similar Treatment as White Women, Black Women have Worse...

Breast cancer is the most common cancer in women in the United States and worldwide. Furthermore, hormone-receptor–positive, axillary node–negative disease accounts for approximately half...

Lymph Node Surgery and Axillary Radiotherapy Yield Comparable 10-year Outcome in...

Results from the randomized, Phase III AMAROS clinical trial (NCT00014612),  presented at the San Antonio Breast Cancer Symposium (SABCS), held December 4–8, 2018, in...

Circulating Tumor Cell Count may Help in Treatment Selection for Metastatic...

Results from the phase III STIC CTC clinical trial, presented at the San Antonio Breast Cancer Symposium (SABCS), held December 4–8, 2018 in San...

Study Shows Low-Dose Tamoxifen to be Safe and Effective in Reducing...

Data from the randomized, Phase III TAM-01 clinical trial, presented at during the San Antonio Breast Cancer Symposium (SABCS), held December 4–8, 2018 in...

Study Shows Accelerated Partial Breast Irradiation Not Equivalent to Whole Breast...

Data presented at the San Antonio Breast Cancer Symposium (SABCS), held December 4–8, 2018 in San Antonio, TX, shows that ipsilateral breast tumor recurrence...

Lifestyle Intervention Associated with Higher Disease-free Survival Rates in Breast Cancer

According to results of a study presented at the San Antonio Breast Cancer Symposium (SABCS), held December 4–8, 2018 in San Antonio, TX, survivors...

Exercise may Improve Cardiovascular Function During Adjuvant Breast Cancer Treatment

According to results of the Energy Balance and Breast Cancer Aspect (EBBA)-II trial (NCT02240836) , sponsored by the Norwegian Research Council, Norwegian Health Authority,...

Latest